GW has been at it for about 20 years so I am a bit amazed that they're not further along. Their path has been with targeted grows and using the plant for their candidates which is kind of puzzling. I think Sativex was doomed because it's orally administered and it contains alcohol which is just nuts. I haven't paid attention to Epidiolex but if I remember correctly, even if it gets approved, it can only be administered for that specific indication. Whereas other drugs that get FDA approval can be administered by doctors however they see fit. It just can't be marketed for anything other than what it was approved for.
News 
Market Data 
Discover 
